Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

760 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Uncertainty of cosmetic evaluation after accelerated partial breast irradiation: interim analysis of a Japanese prospective multi-institutional feasibility study.
Yoden E, Nose T, Otani Y, Asahi S, Tsukiyama I, Dokiya T, Saeki T, Fukuda I, Sekine H, Shikama N, Kumazaki Y, Takahashi T, Yoshida K, Kotsuma T, Masuda N, Nakashima K, Matsumura T, Nakagawa S, Tachiiri S, Moriguchi Y, Itami J, Oguchi M. Yoden E, et al. Among authors: saeki t. Jpn J Radiol. 2017 Jul;35(7):381-388. doi: 10.1007/s11604-017-0640-0. Epub 2017 May 4. Jpn J Radiol. 2017. PMID: 28474300
BiClamp forceps significantly shorten the operation time for breast surgery.
Takeuchi H, Saeki T, Shigekawa T, Sano H, Nakamiya N, Matsuura K, Misumi M, Takahashi T, Fujiuchi N, Okubo K, Osaki A, Sakurai T, Koyama I. Takeuchi H, et al. Among authors: saeki t. Surg Today. 2010 Aug;40(8):706-10. doi: 10.1007/s00595-009-4118-2. Epub 2010 Jul 30. Surg Today. 2010. PMID: 20676852
A multicenter, phase II study of epirubicin/cyclophosphamide followed by docetaxel and concurrent trastuzumab as primary systemic therapy for HER-2 positive advanced breast cancer (the HER2NAT study).
Aogi K, Saeki T, Nakamura S, Kashiwaba M, Sato N, Masuda N, Rai Y, Ohno S, Kuroi K, Nishimura R, Miyakoda K, Akiyama F, Kurosumi M, Ikeda T. Aogi K, et al. Among authors: saeki t. Int J Clin Oncol. 2013 Aug;18(4):598-606. doi: 10.1007/s10147-012-0437-1. Epub 2012 Jul 26. Int J Clin Oncol. 2013. PMID: 22833344 Clinical Trial.
[Treatment of inoperable breast cancer].
Osaki A, Nakamiya N, Saeki T, Matsuura K. Osaki A, et al. Among authors: saeki t. Nihon Rinsho. 2012 Sep;70 Suppl 7:581-6. Nihon Rinsho. 2012. PMID: 23350467 Japanese. No abstract available.
[Front line of sentinel lymph node biopsy].
Takahashi T, Saeki T. Takahashi T, et al. Among authors: saeki t. Gan To Kagaku Ryoho. 2012 Dec;39(13):2475-8. Gan To Kagaku Ryoho. 2012. PMID: 23447838 Japanese. No abstract available.
A randomized, double-blind, controlled study of exemestane versus anastrozole for the first-line treatment of postmenopausal Japanese women with hormone-receptor-positive advanced breast cancer.
Iwata H, Masuda N, Ohno S, Rai Y, Sato Y, Ohsumi S, Hashigaki S, Nishizawa Y, Hiraoka M, Morimoto T, Sasano H, Saeki T, Noguchi S. Iwata H, et al. Among authors: saeki t. Breast Cancer Res Treat. 2013 Jun;139(2):441-51. doi: 10.1007/s10549-013-2573-3. Epub 2013 May 30. Breast Cancer Res Treat. 2013. PMID: 23715630 Free PMC article. Clinical Trial.
760 results